Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Joby Aviation
JOBY
|
$453M |
| 2 |
Datadog
DDOG
|
$423M |
| 3 |
Cloudflare
NET
|
$378M |
| 4 |
Mercado Libre
MELI
|
$311M |
| 5 |
Amazon
AMZN
|
$290M |
Top Sells
| 1 |
Tesla
TSLA
|
$750M |
| 2 |
Booking.com
BKNG
|
$484M |
| 3 |
Netflix
NFLX
|
$450M |
| 4 |
Spotify
SPOT
|
$372M |
| 5 |
Carvana
CVNA
|
$364M |
Sector Composition
| 1 | Consumer Discretionary | 27.35% |
| 2 | Technology | 24.66% |
| 3 | Healthcare | 18.87% |
| 4 | Communication Services | 12.6% |
| 5 | Financials | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Novavax
NVAX
$1.21B
| – | – | -130 | Closed | -$901 |
|
427
Outset Medical
OM
$247M
| – | – | -386 | Closed | -$7.1K |
|
428
ON Semiconductor
ON
$20.3B
| – | – | -619 | Closed | -$51K |
|
429
Opko Health
OPK
$1.1B
| – | – | -6,635 | Closed | -$9.69K |
|
430
Paychex
PAYX
$50.2B
| – | – | -137 | Closed | -$15.7K |
|
431
PagerDuty
PD
$1.54B
| – | – | -565 | Closed | -$19.8K |
|
432
Pfizer
PFE
$141B
| – | – | -466 | Closed | -$19K |
|
433
Piedmont Lithium
PLL
$159M
| – | – | -251 | Closed | -$15.1K |
|
434
Procept Biorobotics
PRCT
$2.23B
| – | – | -435 | Closed | -$12.4K |
|
435
Pure Storage
PSTG
$25.4B
| – | – | -1,480 | Closed | -$37.8K |
|
436
PTC Therapeutics
PTCT
$3.92B
| – | – | -278 | Closed | -$13.5K |
|
437
Peloton Interactive
PTON
$3.1B
| – | – | -2,088,222 | Closed | -$23.7M |
|
438
Qualcomm
QCOM
$173B
| – | – | -202 | Closed | -$25.8K |
|
439
QuidelOrtho
QDEL
$1.95B
| – | – | -128 | Closed | -$11.4K |
|
440
Q2 Holdings
QTWO
$4.92B
| – | – | -517,328 | Closed | -$12.7M |
|
441
Ultragenyx Pharmaceutical
RARE
$2.89B
| – | – | -115 | Closed | -$4.61K |
|
442
RB Global
RBA
$21.3B
| – | – | -1,538,987 | Closed | -$86.6M |
|
443
Regeneron Pharmaceuticals
REGN
$61.5B
| – | – | -54 | Closed | -$44.4K |
|
444
Regenxbio
RGNX
$451M
| – | – | -817 | Closed | -$15.4K |
|
445
Robert Half
RHI
$3.8B
| – | – | -131 | Closed | -$10.6K |
|
446
Rambus
RMBS
$7.94B
| – | – | -740 | Closed | -$37.9K |
|
447
Rollins
ROL
$27.4B
| – | – | -623 | Closed | -$23.4K |
|
448
Seer Inc
SEER
$115M
| – | – | -223 | Closed | -$861 |
|
449
SEI Investments
SEIC
$10.9B
| – | – | -508 | Closed | -$29.2K |
|
450
Stitch Fix
SFIX
$690M
| – | – | -34,610 | Closed | -$177K |
|